Thursday, April 12, 2007
| 9:00 |
Keynote Address- General Session Room
Scott Hamilton, Olympic Gold Medalist & Cancer Survivor Official spokesperson for TARGET HOUSE AT ST. JUDE CHILDREN'S HOSPITAL & THE SCOTT HAMILTON C.A.R.E.S. |
| 9:45 | Networking Break – Exhibit Hall Open |
| 10:15 | Transition time to Oncology Trial Conference Room |
| 10:20 |
Biomarkers in Cancer Drug Development
Panelists:
Renee B Iacona, PhD, MPH, Global Product Statistician, ASTRAZENECA PHARMACEUTICALS Peter F. Lenehan, MD, PhD, Chief Medical Officer, GENETICS SQUARED, INC |
| 10:50 |
Two Shots on Goal - Identifying Sensitive Subpopulations Peter F. Lenehan, MD, PhD, Chief Medical Officer, GENETICS SQUARED, INC |
| 12:00 | Lunch |
| 1:30 |
Case Study
Darrel P. Cohen, M.D., Ph.D., Senior Director, Oncology Clinical Development, PFIZER GLOBAL RESEARCH AND DEVELOPMENT |
| 2:15 |
Imaging in Oncology Clinical Trials: Incorporating Central Review to Maximize Value Giles Boland, M.D, Vice Chairman, Department of Radiology, MASSACHUSETTS GENERAL HOSPITAL, Rick Taranto, MBA, President, WORLDCARE CLINICAL, LLC |
| 3:00 | Conference Concludes |
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved